Dobutamine: a hemodynamic evaluation in children with shock

Area of Science:

• Pediatric Cardiology
• Pharmacology
• Critical Care Medicine

Background:

• Cardiogenic and septic shock in pediatric patients present significant management challenges.
• Understanding the hemodynamic effects of inotropic agents is crucial for optimizing treatment strategies.

Purpose of the Study:

• To evaluate the hemodynamic effects of dobutamine in infants and children with cardiogenic or septic shock.
• To determine the influence of age and diagnosis on dobutamine's efficacy.

Main Methods:

• Dobutamine was administered to 33 pediatric patients at escalating doses (2.5-10.0 micrograms/kg/minute).
• Hemodynamic parameters including cardiac index, systemic arteriolar resistance index, and pressures were monitored.
• Statistical analysis considered the impact of patient age and shock diagnosis.

Main Results:

• Dobutamine significantly increased cardiac index and left ventricular stroke work index.
• Systemic arteriolar resistance index significantly decreased with dobutamine administration.
• No significant changes were observed in heart rate or mean pressures; age and diagnosis impacted responses.

Conclusions:

• Dobutamine demonstrates utility in managing pediatric shock, enhancing cardiac output and reducing systemic resistance.
• Its effectiveness is particularly noted in children over 12 months with cardiogenic shock without severe hypotension.
• Dobutamine represents a valuable pharmacologic option for pediatric hemodynamic support.